La transplantation hépatique après prélèvement à coeur non-battant: expérience de l'Université de LiègeDetry, Olivier ; Seydel, Benoît ; Hans, Marie-France et al(2008) Detailed reference viewed: 40 (8 ULg) Prolonged anhepatic state after early liver graft removalDetry, Olivier ; De Roover, Arnaud ; Delwaide, Jean et alin Hepato-Gastroenterology (2007), 54(79, Oct-Nov), 2109-2112 Two-stage liver transplantation, i.e. salvage emergent total hepatectomy with prolonged anhepatic state, and subsequent liver transplantation, has been described as a life-saving procedure in selected ... [more ▼] Two-stage liver transplantation, i.e. salvage emergent total hepatectomy with prolonged anhepatic state, and subsequent liver transplantation, has been described as a life-saving procedure in selected cases. The principal drawback of two-stage liver transplantation is the fact that anhepatic patient survival only depends on the future availability of a liver graft. The pathophysiologic alterations induced by total hepatectomy are not fully known, as it is not known how long a patient may be anhepatic before it is too late for hope of survival. In this report the authors describe the cases of three liver recipients who had to undergo salvage liver graft removal early during or after liver transplantation as a life-saving maneuver. All were afterwards registered for emergent liver retransplantation. Mean anhepatic period was 20 hours (Range: 17-24 hours). Two patients survived and fully recovered. From this experience and from other cases reported in the literature, the authors concluded that total hepatectomy may be life-saving in some cases if a liver graft is available in a timely manner. [less ▲] Detailed reference viewed: 65 (6 ULg) Complications in living liver donor according to Clavien's classification: An European experienceDe Roover, Arnaud ; Detry, Olivier ; Meurisse, Nicolas et alin Journal of Hepatology (2007), 46(Suppl. 1), 66 Detailed reference viewed: 46 (3 ULg) Cadaveric whole liver transplantation for non-acetaminophen fulminant hepatic failure: A 20-year experienceDetry, Olivier ; De Roover, Arnaud ; Coimbra Marques, Carla et alin Journal of Hepatology (2007), 46(Suppl. 1), 66-67 Detailed reference viewed: 32 (6 ULg) Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: A 20-year experienceDetry, Olivier ; De Roover, Arnaud ; Coimbra Marques, Carla et alin World Journal of Gastroenterology (2007), 13(9), 1427-1430 AIM: To investigate the long-term results of liver transplantation (LT) for non-acetaminophen fulminant hepatic failure (FHF). METHODS: Over a 20-year period, 29 FHF patients underwent cadaveric whole LT ... [more ▼] AIM: To investigate the long-term results of liver transplantation (LT) for non-acetaminophen fulminant hepatic failure (FHF). METHODS: Over a 20-year period, 29 FHF patients underwent cadaveric whole LT. Most frequent causes of FHF were hepatitis B virus and drug-related (not acetaminophen) liver failure. All surviving patients were regularly controlled at the out-patient clinic and none was lost to follow-up. Mean follow-up was 101 mo. RESULTS: One month, one-, five- and ten-year patient survival was 79%, 72%, 68% and 68%, respectively. One month, one-, five- and ten-year graft survival was 69%, 65%, 51% and 38%, respectively. Six patients needed early (< 2 mo) retransplantation, four for primary non-function, one for early acute refractory rejection because of ABO blood group incompatibility, and one for a malignant tumor found in the donor. Two patients with hepatitis B FHF developed cerebral lesions peri-transplantion: One developed irreversible and extensive brain damage leading to death, and one suffered from deep deficits leading to continuous medical care in a specialized institution. CONCLUSION: Long-term outcome of patients transplanted for non-acetaminophen FHF may be excellent. As the quality of life of these patients is also particularly good, LT for FHF is clearly justified, despite lower graft survival compared with LT for other liver diseases. (C) 2007 The WJG Press. All rights reserved. [less ▲] Detailed reference viewed: 72 (21 ULg) Bloodless cadaveric liver transplantation: Experience with Jehovah's witness recipientsDetry, Olivier ; De Roover, Arnaud ; Coimbra Marques, Carla et alin Journal of Hepatology (2007), 46(Suppl. 1), 67 Detailed reference viewed: 33 (16 ULg) 60 h of anhepatic state without neurologic deficitDetry, Olivier ; De Roover, Arnaud ; Delwaide, Jean et alin Transplant International (2006), 19(9), 769-769 Detailed reference viewed: 23 (8 ULg) Right lobe living related liver transplantation in adults without venous drainage of the paramedian sectorDetry, Olivier ; De Roover, Arnaud ; Coimbra Marques, Carla et alin Transplantation Proceedings (2005), 37(6, Jul-Aug), 2865-2868 Introduction. There is some controversy on the necessity of venous reconstruction of the right paramedian sector (segments V and VIII) during right lobe living related liver transplantation. In this ... [more ▼] Introduction. There is some controversy on the necessity of venous reconstruction of the right paramedian sector (segments V and VIII) during right lobe living related liver transplantation. In this report we describe the evolution of posttransplant graft function in five consecutive right lobe recipients without specific drainage of the right paramedian sector. Material and methods. The technique of common right hepatectomy for right lobe graft harvesting and transplantation did not include the middle hepatic vein in the graft. The mean total ischemic time was 51 minutes (ranges: 35 to 64 minutes). The mean graft to recipient weight ratio was 1.35% +/- 0.15%. No patient developed small-for-size syndrome. Results. All patients showed a rise in transaminases with a maximum at postoperative day 2 (mean aspartate aminotransferase: 1067 +/- 432 IU/mL). Liver function improved rapidly, with coagulation normalized at postoperative day 5. Bilirubin decreased progressively to normalize in three patients at postoperative day 14. Ultrasonography and computed tomography demonstrated that the paramedian sector of the right liver was congested, a state that was temporary with normalization of the liver tests and congestion disappeared at follow-up. No complication was linked to congestion. Discussion. This series showed that in right lobe liver transplantation with a relatively large-size graft, reconstruction of the hepatic veins of the paramedian sector may not be necessary despite the induction of some degree of venous congestion. In smaller grafts, this congestion might be avoided by reconstruction of the large veins draining segments V and VIII. [less ▲] Detailed reference viewed: 28 (8 ULg) One year experience of the Belgian Liver Intestine Comittee (BLIC) intranet database; ; et al in Acta Gastro-Enterologica Belgica (2001, January), 64(1), 7 Detailed reference viewed: 19 (3 ULg) Organ Donors with Primary Central Nervous System TumorDetry, Olivier ; Honore, Pierre ; Hans, Marie-France et alin Transplantation (2000), 70(1), 244-8251-2 Patients with primary central nervous system (CNS) tumor have been accepted for organ donation because these tumors very rarely spread outside the CNS. However several case reports of CNS tumor ... [more ▼] Patients with primary central nervous system (CNS) tumor have been accepted for organ donation because these tumors very rarely spread outside the CNS. However several case reports of CNS tumor transferral with organ transplantation recently challenged this attitude. Some risk factors for extraneural spread of CNS tumors have been determined, but the absence of risk factors does not exclude the possibility of metastases. To our knowledge, 13 cases of CNS tumor transferral with organ transplantation (one heart, three livers, eight kidneys, one kidney/pancreas) have been reported in the literature. Even if no prospective evaluation of the CNS tumor transmission risk with transplantation has been undergone, this risk may be estimated between a little more than 0% and 3% from retrospective series. The authors consider that patients with CNS tumor should be accepted as donors as long as the risk of dying on the waiting lists is significantly higher than the tumor transferral risk. Therefore the authors would have no restriction for transplanting organs from donors with benign or low-grade CNS tumor. For high-grade tumors, the authors would consider these donors as "marginal donors," and balance the risk of tumor transmission with the medical condition of the recipient. [less ▲] Detailed reference viewed: 21 (5 ULg) Organ donors with primary central nervous system tumorDetry, Olivier ; Honore, Pierre ; Hans, Marie-France et alin Transplantation (2000), 70(1), 244-8251-2 Patients with primary central nervous system (CNS) tumor have been accepted for organ donation because these tumors very rarely spread outside the CNS. However several case reports of CNS tumor ... [more ▼] Patients with primary central nervous system (CNS) tumor have been accepted for organ donation because these tumors very rarely spread outside the CNS. However several case reports of CNS tumor transferral with organ transplantation recently challenged this attitude. Some risk factors for extraneural spread of CNS tumors have been determined, but the absence of risk factors does not exclude the possibility of metastases. To our knowledge, 13 cases of CNS tumor transferral with organ transplantation (one heart, three livers, eight kidneys, one kidney/pancreas) have been reported in the literature. Even if no prospective evaluation of the CNS tumor transmission risk with transplantation has been undergone, this risk may be estimated between a little more than 0% and 3% from retrospective series. The authors consider that patients with CNS tumor should be accepted as donors as long as the risk of dying on the waiting lists is significantly higher than the tumor transferral risk. Therefore the authors would have no restriction for transplanting organs from donors with benign or low-grade CNS tumor. For high-grade tumors, the authors would consider these donors as "marginal donors," and balance the risk of tumor transmission with the medical condition of the recipient. [less ▲] Detailed reference viewed: 24 (8 ULg) Malignancy transplantation with heart graftDetry, Olivier ; Hans, Marie-France ; Defraigne, Jean-Olivier et alin Journal of Heart & Lung Transplantation (1998), 17(3), 331-332 Detailed reference viewed: 11 (2 ULg) |
||